Cargando…

Invariant NKT cells: Killers and conspirators against cancer

Although invariant natural killer T (iNKT) cells influence antitumor responses indirectly by secreting cytokines and promoting the cytolytic functions of T and NK cells, we find that iNKT cells mediate direct tumoricidal activity in vitro and significantly inhibit tumor growth in vivo, even in the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bassiri, Hamid, Das, Rupali, Nichols, Kim E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926875/ https://www.ncbi.nlm.nih.gov/pubmed/24575380 http://dx.doi.org/10.4161/onci.27440

Ejemplares similares

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013)

Cancer-associated fibroblasts and macrophages: Friendly conspirators for malignancy
por: Chiarugi, Paola
Publicado: (2013)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

Antitumor Responses of Invariant Natural Killer T Cells
por: Altman, Jennie B., et al.
Publicado: (2015)

Invariant natural killer T cells reconstitution and the control of leukemia relapse in pediatric haploidentical hematopoietic stem cell transplantation
por: Casorati, Giulia, et al.
Publicado: (2012)

Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control
por: Guan, Peng, et al.
Publicado: (2020)

Humanizing mice for the identification of novel anticancer lipids targeting iNKT cells
por: Wen, Xiangshu, et al.
Publicado: (2013)

Activity of cytokine-induced killer cells against bone and soft tissue sarcoma
por: Sangiolo, Dario, et al.
Publicado: (2014)

Immunosurveillance of senescent cancer cells by natural killer cells
por: Iannello, Alexandre, et al.
Publicado: (2014)

KLRG1(+) natural killer cells protect against pulmonary metastatic disease by immunosurveillance
por: Renner, Philipp, et al.
Publicado: (2014)

ATM activation mediates anticancer immunosurveillance by natural killer and T cells
por: Tang, Melissa LF, et al.
Publicado: (2013)

Natural killer T cell strategies to combat Epstein–Barr virus infection
por: Priatel, John J, et al.
Publicado: (2014)

A critical role for natural killer cells in dendritic cell-based anticancer immunotherapy
por: McLellan, Alexander D
Publicado: (2014)

Non-classical MHC Class I molecules regulating natural killer cell function
por: Smyth, Mark J., et al.
Publicado: (2013)

Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotype
por: Kellner, Christian, et al.
Publicado: (2013)

Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
por: Zhao, Jie, et al.
Publicado: (2014)

Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target
por: Noman, Muhammad Zaeem, et al.
Publicado: (2018)

Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
por: van Luijn, Marvin M., et al.
Publicado: (2012)

Primary Mouse Invariant Natural Killer T (iNKT) Cell Purification and Transduction
por: Delfanti, Gloria, et al.
Publicado: (2023)

Lin28 and HER2: Two stem cell regulators conspire to drive aggressive breast cancer
por: Malik, Fayaz, et al.
Publicado: (2012)

All the conspirators /
por: Isherwood, Christopher, 1904-1986
Publicado: (1967)

Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
por: Jinesh G., Goodwin, et al.
Publicado: (2012)

The dual targeting of immunosuppressive cells and oxidants promotes effector and memory T-cell functions against lung cancer
por: Sawant, Anandi, et al.
Publicado: (2014)

Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer
por: Peng, Weiyi, et al.
Publicado: (2013)

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023)

PARP1 inhibition elicits immune responses against non-small cell lung cancer
por: Juncheng, Pan, et al.
Publicado: (2022)

Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody
por: Patel, Nishant P., et al.
Publicado: (2020)

Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?
por: Cioffi, Michele, et al.
Publicado: (2012)

Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
por: Morales-Kastresana, Aizea, et al.
Publicado: (2014)

Spontaneous focal activation of invariant natural killer T (iNKT) cells in mouse liver and kidney
por: Zeng, Jia, et al.
Publicado: (2010)

Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer
por: Herr, Ingrid, et al.
Publicado: (2012)

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
por: Bazhin, Alexandr V, et al.
Publicado: (2013)

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

NK cell-released exosomes: Natural nanobullets against tumors
por: Fais, Stefano
Publicado: (2013)

SLAM-SAP-Fyn: Old Players with New Roles in iNKT Cell Development and Function
por: Bahal, Devika, et al.
Publicado: (2019)

The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
por: Demaria, Sandra, et al.
Publicado: (2013)

A fasting-mimicking diet and vitamin C: turning anti-aging strategies against cancer
por: Di Tano, Maira, et al.
Publicado: (2020)

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma
por: Messaoudene, Meriem, et al.
Publicado: (2014)

Tracking tumor evolution one-cell-at-a-time
por: Sharma, Ankur, et al.
Publicado: (2019)

Survivin the battle against immunosuppression
por: Manuel, Edwin R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q8l4d8s585v8uko8sm9iaspfg1